Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: H&R GmbH & Co. KGaA

Market Cap 179M 203M 165M 154M 289M 19.27B 294M 1.98B 765M 9.45B 763M 747M 32.85B P/E 2026 *
30.5x
P/E 2027 * 22.5x
Enterprise Value 335M 381M 308M 289M 541M 36.1B 550M 3.7B 1.43B 17.71B 1.43B 1.4B 61.56B EV / Sales 2026 *
0.26x
EV / Sales 2027 * 0.25x
Free-Float
22.35%
Yield 2026 *
1.04%
Yield 2027 * 1.04%
05-15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-31 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
11-14 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25-08-24 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
25-08-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-15 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
25-05-13 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-16 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
25-04-08 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-26 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
25-03-26 H&R GmbH & Co. KGaA Announces Postponement of the Publication of the Consolidated Financial Statements and the Annual Report 2024 CI
1 day+5.87%
1 week-0.64%
Current month+2.66%
1 month+1.98%
3 months+20.89%
6 months+7.67%
Current year+9.20%
1 week 4.53
Extreme 4.53
4.69
1 month 4.47
Extreme 4.47
4.77
Current year 3.83
Extreme 3.83
4.77
1 year 3.83
Extreme 3.83
5.02
3 years 3.22
Extreme 3.22
5.28
5 years 3.22
Extreme 3.22
10.25
10 years 3.22
Extreme 3.22
19.35
Manager TitleAgeSince
Chief Executive Officer 61 2015-12-31
Investor Relations Contact - 2005-12-31
Director TitleAgeSince
Chairman 62 2012-04-16
Director/Board Member 71 2011-04-30
Director/Board Member 69 2011-04-30
Change 5-day change 1-year change 3-year change Capi.($)
+5.87%-0.64% - - 203M
+2.42%+2.13%+6.34%+29.14% 120B
+0.09%-2.73%-2.46%-39.94% 42.67B
+1.31%+34.35%+470.11%+96.56% 38.7B
-2.02%+3.90%+38.59%-18.88% 33.57B
+0.87%-0.50%+32.15%+71.84% 23.47B
-3.27%-4.16%+474.99%+676.13% 20.61B
-5.62%-4.83%+115.74%+9.40% 19.42B
-2.57%+2.25%+27.96%+27.42% 18.84B
-3.46%+0.32%+72.43%+252.52% 18.63B
Average -0.64%+3.49%+137.32%+122.69% 37.35B
Weighted average by Cap. +0.03%+3.50%+103.55%+77.12%

Financials

2026 *2027 *
Net sales 1.29B 1.47B 1.19B 1.12B 2.09B 139B 2.13B 14.31B 5.54B 68.44B 5.53B 5.41B 238B 1.33B 1.51B 1.23B 1.15B 2.15B 143B 2.19B 14.72B 5.7B 70.38B 5.68B 5.56B 245B
Net income 5.85M 6.66M 5.39M 5.05M 9.45M 631M 9.61M 64.71M 25.05M 309M 24.99M 24.45M 1.08B 8M 9.1M 7.37M 6.9M 12.92M 862M 13.14M 88.46M 34.24M 423M 34.16M 33.43M 1.47B
Net Debt 156M 178M 144M 135M 252M 16.83B 257M 1.73B 669M 8.26B 667M 653M 28.71B 158M 180M 145M 136M 255M 17.02B 259M 1.75B 676M 8.35B 674M 660M 29.02B
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,692
Date Price Change
26-06-24 4.630 +0.65%
26-06-23 €4.600 -1.92%
26-06-22 €4.690 +3.53%
26-06-19 €4.530 -0.66%
26-06-18 €4.560 -2.15%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
4.800EUR
Average target price
4.300EUR
Spread / Average Target
-10.42%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!